Cumulus Oncology

About:

Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.

Website: https://www.cumulusoncology.com/

Top Investors: Scottish Enterprise, Eos, Scottish National Investment Bank

Description:

Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We target key pathways to improve the efficacy and outcomes of current and experimental therapies. Cumulus has the backing of a successful entrepreneur in the oncology field and is led by a team of senior professionals and industry partners from across the drug discovery and development sector. Together, we offer a wealth of experience and deep insights into optimum approaches for improved cancer patient outcomes.

Total Funding Amount:

13.1M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2017-01-01

Contact Email:

cwareing(AT)cumulusoncology.com

Founders:

Clare Wareing

Number of Employees:

11-50

Last Funding Date:

2024-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai